ELITEK (rasburicase) Patient Assistance Program
Elitek is given during some of the hardest days in oncology — the start of treatment for aggressive leukemias and lymphomas. Its cost runs through hospital billing, not your pharmacy — and understanding that is most of protecting your family from it. We handle the rest for a flat $69.95 per month.
- Honest Billing Guidance — This Drug Is Bought And Billed By The Hospital, Not You
- Sanofi Patient Connection Filing For Eligible Uninsured Patients (400% FPL)
- Hospital Financial Assistance Pursued — Nearly Every Cancer Center Has It
- Comprehensive Support Across The Whole Treatment Episode
- Medicare Part B/Part A Math Explained For Families
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Elitek (Rasburicase) Prevents And Treats Tumor Lysis Syndrome — The Dangerous Flood Of Uric Acid Released When Chemotherapy Rapidly Kills Large Numbers Of Cancer Cells — Given As A Short IV Course (Up To 5 Days, Once Per Treatment) In Leukemia, Lymphoma, And Fast-Growing Solid Tumors.
- The Vials Are Expensive — About $1,095 (1.5 mg) To $5,469 (7.5 mg), Weight-Based Dosing — But Patients Don’t Buy Them: Elitek Is Administered By Clinicians And Billed Inside The Hospital Or Clinic Episode, Under Medicare Part B (Outpatient) Or Bundled Into Part A (Inpatient).
- Your Real Exposure Is Cost-Sharing On The Episode, Not The Drug: 20% Part B Coinsurance Absorbed By Supplements, Plan Out-Of-Pocket Maximums For The Commercially Insured, And Hospital Financial Assistance For Everyone Else.
- The Sanofi Patient Connection Program Covers Elitek For Eligible Uninsured Patients With Household Income Up To 400% Of The Federal Poverty Level ($63,840 Single / $132,000 Family Of Four) — Filed Through The Treating Facility.
What Is Elitek Prescription Assistance Program?
Elitek’s assistance story is different from every pharmacy drug on this site because the patient never fills it: rasburicase is infused by clinicians during the opening days of cancer treatment, purchased by the facility, and billed inside the treatment episode — Medicare Part B in outpatient settings (20% coinsurance, no Part D cap involvement), bundled into the Part A stay when inpatient, and folded into your plan’s medical benefit when commercially insured. That means the protective moves are episode-level: a Medigap supplement or Advantage out-of-pocket maximum absorbing Part B coinsurance; your commercial plan’s OOP max doing the same; hospital financial assistance — which nearly every cancer center offers and few families request — covering gaps; and for the eligible uninsured, the Sanofi Patient Connection program (1-888-847-4877), which lists Elitek and covers patients up to 400% of the Federal Poverty Level, filed with the treating facility’s help. Families meet this drug at the worst possible moment to also be studying hospital billing — which is precisely the point of handing it to us. For a flat $69.95 per month, our Patient Advocates coordinate the facility’s financial office, the Sanofi filing where it applies, and the rest of a treatment-season medication list.
Pharmacy Price Comparison
- Without assistance, Elitek costs roughly $5,500–$8,500 per dose. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Hospital pharmacy | ~$8,000/dose | Save substantially |
| Inpatient billing | ~$8,500/dose | Save substantially |
| Specialty Pharmacy | ~$6,500/dose | Save substantially |
| Walmart | ~$6,000/dose | Save substantially |
Costco | ~$5,800/dose | Save substantially |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Elitek Prescription Program?
The Patient Assistance Program is free to apply for and provides Elitek at no medication cost if approved. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Elitek:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $5,500–$8,500 per dose per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Elitek assistance.
- You Or A Family Member Is Starting Treatment Where TLS Prevention Is Planned — The Coverage Check Belongs In The Same Week
- You’re Uninsured With Household Income At Or Below 400% FPL — The Sanofi Program Applies
- You’re On Medicare Without A Supplement — The 20% Exposure Deserves A Plan
- A Facility Bill Already Arrived And It’s Frightening — Hospital Assistance And Bill Review Still Apply After The Fact
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Elitek:
Elitek (rasburicase) is a recombinant enzyme that destroys uric acid — deployed in the first days of cancer treatment, when chemotherapy killing a large tumor burden fast can flood the blood with cell contents and shut down the kidneys.
How Elitek Works:
When aggressive chemotherapy lyses masses of cancer cells at once, their contents — potassium, phosphate, and the purines that become uric acid — spill into the bloodstream faster than kidneys can clear them: tumor lysis syndrome, which can cause kidney failure and fatal arrhythmias within days. Rasburicase is the enzyme humans lack, converting uric acid into a compound the kidneys clear easily — dropping levels within hours, far faster than allopurinol can prevent their rise. It’s reserved for high-risk starts: acute leukemias, high-grade lymphomas like Burkitt, and bulky fast-growing tumors.
Form and Use:
An IV infusion over 30 minutes, 0.2 mg/kg once daily for up to five days — and the label recommends only one course per lifetime, since antibodies form. That single-course design shapes everything financial: there is exactly one bill, structured by whatever coverage exists during that one week — which is why the coverage check belongs in the same conversation as the treatment plan.
Generic Availability:
No generic or biosimilar rasburicase is marketed in the U.S. Allopurinol — pennies, oral — is the standard prevention for lower-risk patients, and febuxostat exists as another oral option; risk stratification, not price, decides who needs rasburicase, and payer policies increasingly enforce exactly that.
Warnings:
Elitek carries boxed warnings for fatal anaphylaxis (monitored administration), severe hemolysis in G6PD deficiency (screening required in higher-risk ancestries before use — a contraindication, not a caution), methemoglobinemia, and laboratory interference (blood samples for uric acid must go on ice, or the enzyme keeps working in the tube and falsely lowers readings). All are managed by the treating team; families should simply know the G6PD screen is supposed to happen.
FAQ (Frequently Asked Questions)
How Much Does Elitek Cost Without Insurance?
Elitek costs approximately $5,500–$8,500 per single dose. Most patients receive 1 dose (sometimes up to 5 daily doses for severe TLS). Through AffordMyPrescriptions, qualifying patients receive Elitek at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
How Much Does Elitek Cost?
About $1,095 per 1.5 mg vial and $5,469 per 7.5 mg vial, dosed by weight for up to five days — a course can run five figures on the facility’s invoice. But patients don’t purchase it: it bills inside the treatment episode, and your exposure is your plan’s episode cost-sharing, which the routes on this page contain.
Will I See A Separate Bill For Elitek?
Usually a line item inside the facility’s outpatient or inpatient billing, weeks later. Outpatient Medicare runs it under Part B (20% coinsurance, supplement-absorbable); inpatient bundles it into the Part A stay; commercial plans run it through the medical benefit toward your out-of-pocket max. If a bill already arrived and looks wrong, bill review is a real service — bring it to us.
Does The Sanofi Program Cover Elitek?
Yes — Elitek is on the Sanofi Patient Connection medication list, covering eligible uninsured patients with household income up to 400% of the Federal Poverty Level ($63,840 single / $132,000 family of four). Filing runs through the treating facility; we coordinate it.
Why Did The Insurance Company Question It?
2026-era policies commonly restrict rasburicase to high-risk TLS patients (or intermediate-risk with kidney dysfunction) and require documented G6PD screening — criteria the treating team almost always meets but must paper correctly. That’s a facility-and-plan conversation; we monitor it so a documentation gap never becomes a family’s bill.
Is There A Cheaper Alternative?
For lower-risk patients, oral allopurinol — costing pennies — is standard prevention, and risk level, not preference, decides. If rasburicase was chosen, it’s because the risk profile demanded it; the affordability work is episode-level, not substitution.
What Is The G6PD Test About?
Rasburicase produces hydrogen peroxide as it works; in G6PD deficiency (more common in African, Mediterranean, and Southeast Asian ancestry), that triggers severe hemolysis — so screening before use is required in higher-risk patients. It protects you; make sure it happened.
What If I’m Uninsured And Treatment Can’t Wait?
Treatment proceeds — EMTALA and oncology practice don’t hold TLS prevention hostage to coverage. The financial work happens in parallel: the Sanofi filing, hospital charity care (which often applies retroactively), and bill review afterward. Contact us the same week, and we’ll run all three.
Take Control of Your Medication Costs
Elitek is given once, at the start, when families have the least attention to spare for billing — which is exactly why the coverage check should travel with the treatment plan. We make that happen. Check your eligibility today; the pre-qualification review is free, and if we can’t help you, you pay nothing.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.